Trulieve Cannabis Corp.
TRUL
CNSX
| Weiss Ratings | TRUL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | TRUL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | TRUL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.14 | |||
| Price History | TRUL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 4.07% | |||
| 30-Day Total Return | -11.65% | |||
| 60-Day Total Return | -16.35% | |||
| 90-Day Total Return | -61.63% | |||
| Year to Date Total Return | -28.44% | |||
| 1-Year Total Return | -51.88% | |||
| 2-Year Total Return | -31.93% | |||
| 3-Year Total Return | -74.38% | |||
| 5-Year Total Return | -45.47% | |||
| 52-Week High % Change | -70.45% | |||
| 52-Week Low % Change | 2.43% | |||
| Price | TRUL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $20.00 | |||
| 52-Week Low Price | $5.77 | |||
| 52-Week Low Price (Date) | Mar 05, 2025 | |||
| 52-Week High Price (Date) | Apr 30, 2024 | |||
| Valuation | TRUL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 783.33M | |||
| Enterprise Value | 1.30B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.82 | |||
| Earnings Per Share Growth | -70.71% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.95 | |||
| Price/Book (Q) | 0.89 | |||
| Enterprise Value/Revenue (TTM) | 1.09 | |||
| Price | $6.14 | |||
| Enterprise Value/EBITDA (TTM) | 5.01 | |||
| Enterprise Value/EBIT | 14.02 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | TRUL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 189.96M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | TRUL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 850 480 7955 | |||
| Address | 6749 Ben Bostic Road Quincy, FL 32351 | |||
| Website | www.trulieve.com | |||
| Country | United States | |||
| Year Founded | 1940 | |||
| Profitability | TRUL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 7.79% | |||
| Profit Margin | -13.07% | |||
| Management Effectiveness | TRUL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 2.06% | |||
| Return on Equity | -- | |||
| Income Statement | TRUL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.19B | |||
| Total Revenue (TTM) | 1.19B | |||
| Revenue Per Share | $6.25 | |||
| Gross Profit (TTM) | 715.75M | |||
| EBITDA (TTM) | 258.86M | |||
| EBIT (TTM) | 92.49M | |||
| Net Income (TTM) | -155.11M | |||
| Net Income Avl. to Common (TTM) | -155.11M | |||
| Total Revenue Growth (Q YOY) | 4.94% | |||
| Earnings Growth (Q YOY) | -65.21% | |||
| EPS Diluted (TTM) | -0.82 | |||
| EPS Diluted Growth (Q YOY) | -77.90% | |||
| Balance Sheet | TRUL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 299.20M | |||
| Cash Per Share (Q) | $1.58 | |||
| Total Current Assets (Q) | 604.56M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.25B | |||
| Current Ratio (Q) | 4.365 | |||
| Book Value Per Share (Q) | $6.60 | |||
| Total Assets (Q) | 2.87B | |||
| Total Current Liabilities (Q) | 138.49M | |||
| Total Debt (Q) | 825.47M | |||
| Total Liabilities (Q) | 1.62B | |||
| Total Common Equity (Q) | 1.26B | |||
| Cash Flow | TRUL - CNSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -206.62M | |||
| Cash from Financing (TTM) | -33.44M | |||
| Net Change in Cash (TTM) | 31.73M | |||
| Levered Free Cash Flow (TTM) | 52.56M | |||
| Cash from Operations (TTM) | 271.79M | |||
